EPCAM and nasopharyngeal carcinoma: In cancer cells, EpCAM has proven to be a stem cell marker and maintains and promotes cell stemness in a range of cancers, including hepatocellular carcinoma [71], nasopharyngeal carcinoma [72], non-small-cell lung cancer [73], colorectal cancer [74], and gastric cancer [75].